Aspirus Removes COVID-19 Masking Requirements, Adjusts Additional Guidelines
4/27/2023
Patients, visitors and
staff will no longer be required to wear masks in most situations across all
Aspirus Health facilities starting May 1, 2023.
Masks will be made
available for any patients and visitors who choose to wear them. Masks will
also continue to be worn by Aspirus staff as part of normal practice during
procedures and other patient care as indicated by standard policies and
procedures.
“All COVID-related
guidelines were created to ensure the safest possible environment for everyone
who enters Aspirus facilities,” said Jeff Wicklander, Aspirus Senior Vice
President, and President of Aspirus Wausau Hospital. “We have been eager to
remove restrictions for some time, but the COVID activity data we actively
review hasn’t supported taking earlier action. We thankfully have experienced a
sustained period of low COVID-19 burden on our health system, so now is the
time to safely make this positive change for our employees and those we serve.”
Aspirus is also
adjusting additional guidelines in advance of the federal COVID-19 public
health emergency ending on May 11:
Visitor guidelines – The number of patient
visitors will no longer be restricted unless necessary in specific
circumstances related to patient care or safety.
COVID-19 testing – Testing will no longer be
required for patients prior to hospital admission if they have no COVID-19
symptoms. Aspirus previously discontinued COVID testing prior to surgical
procedures on March 1 for patients without symptoms.
Aspirus reminds
community members to be considerate when visiting loved ones in a hospital or
clinic setting. Individuals with active symptoms of respiratory illness are
encouraged to stay home unless they are seeking care.
Patients can continue
to utilize Aspirus for any COVID-related health needs, including vaccination
and testing for which appointments can be made through the MyAspirus website or
mobile app. The Aspirus COVID-19 call center also remains available at 1-844-568-0701
or 715-843-1454. Additional information can be found online at
aspirus.org/covid19.
Back to all Posts